Ticker Scorecard - AVXL Basics Company: Anavex Life Sciences Corp. IPO Date: October 7, 2015 Sector: Healthcare Industry: Biotech Market Cap: $710.29M Activated in VL: True Average Daily Range Avg Daily Range: $0.24 | 3.47% Avg Daily Range (30 D): $0.37 | 3.62% Avg Daily Range (90 D): $0.40 | 4.45% Institutional Daily Volume Avg Daily Volume: .98M Avg Daily Volume (30 D): 1.25M Avg Daily Volume (90 D): 1.44M Trade Size Avg Trade Size (Sh.): 160 Avg Trade Size (Sh.) (30 D): 100 Avg Trade Size (Sh.) (90 D): 108 Institutional Trades Total Inst.Trades: 1,172 Avg Inst. Trade: $1.51M Avg Inst. Trade (30 D): $1.03M Avg Inst. Trade (90 D): $1.2M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.62M Avg Closing Trade (30 D): $1.03M Avg Closing Trade (90 D): $1.28M Avg Closing Volume: 170.59K     News Dec 27, 2024 @ 3:08 PM Anavex Life Sciences: Short-Squeeze Target Gains T... Source: Thomas Hughes Dec 23, 2024 @ 11:26 AM US Stocks To Open Higher As Wall Street Expects 'S... Source: Rishabh Mishra Nov 8, 2024 @ 11:28 PM Friday's Top 5 Trending Stocks: What's The Scoop O... Source: Erica Kollmann Sep 5, 2024 @ 12:00 PM Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwr... Source: N/A Jul 28, 2024 @ 9:00 PM Results from Anavex Life Sciences Landmark Phase I... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.14 $-.14 $-.52 Diluted EPS $-.14 $-.14 $-.52 Revenue $ 1.39M $ 1.76M $ 7.32M Gross Profit $ $ $ Net Income / Loss $ -12.11M $ -11.62M $ -43M Operating Income / Loss $ -13.59M $ -14.34M $ -52.88M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio     Splits Oct 07, 2015:   4:1 Jun 12, 2006:   1:6